当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析 - 现金流量表

复星医药

(600196)

  

流通市值:526.02亿  总市值:663.29亿
流通股本:21.18亿   总股本:26.71亿

现金流量表

报告期2024-12-312024-09-302024-06-302024-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金41,012,673,920.7530,140,941,020.1919,939,164,414.429,824,877,278.48
收到的税费返还481,786,382.91396,176,187.19230,414,610.43106,375,698.71
收到其他与经营活动有关的现金1,677,687,518.111,014,810,121.01575,493,793.37369,397,090.49
经营活动现金流入的平衡项目0000
经营活动现金流入小计43,172,147,821.7731,551,927,328.3920,745,072,818.2210,300,650,067.68
购买商品、接受劳务支付的现金15,087,001,072.3711,113,466,213.167,067,198,571.363,387,898,596.32
支付给职工以及为职工支付的现金11,060,190,509.888,472,222,959.745,888,679,822.093,129,381,997.2
支付的各项税费2,606,074,067.941,845,379,714.81,344,936,192.55640,089,622.64
支付其他与经营活动有关的现金9,941,900,909.367,134,221,085.524,537,254,334.222,225,967,746.49
经营活动现金流出的平衡项目0000
经营活动现金流出小计38,695,166,559.5528,565,289,973.2218,838,068,920.229,383,337,962.65
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额4,476,981,262.222,986,637,355.171,907,003,898917,312,105.03
二、投资活动产生的现金流量:
收回投资收到的现金409,580,356.92334,148,666.439,146,222.0319,396,578.04
取得投资收益收到的现金1,088,797,294.921,019,256,256.61235,720,364.91138,607,795.3
处置固定资产、无形资产和其他长期资产收回的现金净额457,808,960.28238,760,527.638,705,904.261,170,123.53
处置子公司及其他营业单位收到的现金净额131,424,365.62138,522,994.25134,053,430.37138,268,977.45
收到的其他与投资活动有关的现金317,711,213.1193,073,923.2398,375,301.9479,491,631.81
投资活动现金流入的平衡项目0000
投资活动现金流入小计2,405,322,190.851,823,762,368.12516,001,223.51376,935,106.13
购建固定资产、无形资产和其他长期资产支付的现金4,410,191,178.593,026,949,825.292,093,357,052.051,254,450,607.88
投资支付的现金846,041,301.52931,718,461.75638,038,447.737,181,529.25
取得子公司及其他营业单位支付的现金215,794,112.61-41,979,707.88-
支付其他与投资活动有关的现金546,618,969.35304,806,549.95392,574,930.06276,434,134.54
投资活动现金流出的平衡项目0000
投资活动现金流出小计6,018,645,562.074,263,474,836.993,165,950,137.691,568,066,271.67
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-3,613,323,371.22-2,439,712,468.87-2,649,948,914.18-1,191,131,165.54
三、筹资活动产生的现金流量:
吸收投资收到的现金204,728,600.1168,075,471.89106,070,436.32114,182,753.68
其中:子公司吸收少数股东投资收到的现金204,728,600.1168,075,471.89106,070,436.32114,182,753.68
取得借款收到的现金30,931,111,057.5121,739,468,572.5915,874,396,007.467,989,226,244.59
收到其他与筹资活动有关的现金2,233,435,288.692,057,595,013.831,932,789,359.0174,615,613.82
筹资活动现金流入平衡项目0000
筹资活动现金流入小计33,369,274,946.323,965,139,058.3117,913,255,802.798,178,024,612.09
偿还债务支付的现金30,520,787,294.3321,800,975,343.7715,728,585,194.37,630,293,087.89
分配股利、利润或偿付利息支付的现金2,461,097,387.212,053,832,098.21846,641,558.79344,870,822.69
其中:子公司支付给少数股东的股利、利润401,677,759.28354,336,577.14182,018,449.2613,489,521.08
支付其他与筹资活动有关的现金1,389,976,602.12612,621,029.02247,464,873.84104,223,077.91
筹资活动现金流出平衡项目0000
筹资活动现金流出小计34,371,861,283.6624,467,428,47116,822,691,626.938,079,386,988.49
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-1,002,586,337.36-502,289,412.691,090,564,175.8698,637,623.6
四、汇率变动对现金及现金等价物的影响27,989,327.43-69,635,970.1417,131,450.2123,437,769.89
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-110,939,118.93-25,000,496.53364,750,609.89-151,743,667.02
加:期初现金及现金等价物余额9,502,388,906.049,502,388,906.049,502,388,906.049,502,388,906.04
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额9,391,449,787.119,477,388,409.519,867,139,515.939,350,645,239.02
补充资料:
净利润3,512,440,385-1,549,731,977.11-
资产减值准备96,569,884.79-58,211,200.4-
固定资产和投资性房地产折旧1,543,138,675.38-741,754,366.29-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧1,543,138,675.38-741,754,366.29-
无形资产摊销1,038,687,347.67-523,338,046.4-
长期待摊费用摊销169,436,132.07-79,783,373.63-
处置固定资产、无形资产和其他长期资产的损失-371,013,112.68--716,943.9-
固定资产报废损失21,714,578.69-1,223,970.55-
公允价值变动损失115,939,368.11-282,397,883.66-
财务费用1,254,072,720.22-623,109,420.59-
投资损失-2,104,607,405.87--1,061,766,335.39-
递延所得税-360,778,770.32--82,230,621.41-
其中:递延所得税资产减少-254,965,765.39--35,681,035.26-
递延所得税负债增加-105,813,004.93--46,549,586.15-
存货的减少238,192,005.32--5,741,136.31-
经营性应收项目的减少-397,523,060.54--269,894,611.21-
经营性应付项目的增加-830,705,049.71--715,515,225.74-
不涉及现金收支的投资和筹资活动金额其他项目853,585,924.85---
现金的期末余额9,391,449,787.11-9,867,139,515.93-
减:现金的期初余额9,502,388,906.04-9,502,388,906.04-
公告日期2025-03-262024-10-302024-08-282024-04-30
审计意见(境内)标准无保留意见
TOP↑